Vericel (VCEL) Current Deferred Revenue (2015 - 2018)
Vericel's (VCEL) quarterly Current Deferred Revenue came in at $566000.0 in Q4 2018, up 34.76% year-on-year from $420000.0 in Q4 2017, and up 5.99% quarter-over-quarter from $534000.0 in Q3 2018.
Vericel (VCEL) Current Deferred Revenue (2015 - 2018) Analysis & Trends
Vericel has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $566000.0 for Q4 2018.
- Current Deferred Revenue for Q4 2018 came in at $566000.0, up 34.76% year-over-year; the trailing twelve-month figure through Dec 2018 was $566000.0 (up 34.76% YoY), and the FY2018 annual result was $566000.0, up 34.76% from the prior year.
- Current Deferred Revenue came in at $566000.0 for Q4 2018 at Vericel, up from $534000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $566000.0 in Q4 2018 to a low of $3000.0 in Q4 2016.
- The 4-year median for Current Deferred Revenue is $426000.0 (2018), against an average of $362444.4.
- Across the five-year window, Current Deferred Revenue slumped 97.46% in 2016 and soared 13900.0% in 2017, its largest moves.
- Vericel's Current Deferred Revenue stood at $118000.0 in 2015, then plunged by 97.46% to $3000.0 in 2016, then jumped by 13900.0% to $420000.0 in 2017, then soared by 34.76% to $566000.0 in 2018.
- The last three Current Deferred Revenue figures came in at $566000.0 (Q4 2018), $534000.0 (Q3 2018), and $503000.0 (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 566,000.00 |
| Sep 30, 2018 | 534,000.00 |
| Jun 30, 2018 | 503,000.00 |
| Mar 31, 2018 | 426,000.00 |
| Dec 31, 2017 | 420,000.00 |
| Dec 31, 2016 | 3,000.00 |
| Sep 30, 2016 | 232,000.00 |
| Jun 30, 2016 | 460,000.00 |
| Dec 31, 2015 | 118,000.00 |